Synthesis of the c1 - c28 fragment of spongistatin

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Project objective

Spongistatin 1, 1, is a member of a new class of naturally occuring marine metabolites who have potent potent antitumor activity. Spongistatine 1 is one of the most potent inhibitors of cancer cell growth known and is active against a set of tumors including human melanoma, brain, lung, ovarian and colon cancer. As the low ability of this compound 1 from its natural source is an obstacle for in vivo screening, a total synthesis of this natural product has been planned. This synthesis would also be used for the preparation of structurally close analogues which would in elucidate the structure/activity relationships of this class of Compounds. The structure of spongistatin 1 is based upon structurally unique macrocyclic lacton containing two spiroketals, two C-glycosides, twenty-four stereogenic centres and a diverse array of functionality. It can devide into two halves: Synthesis of Cl-C28 fragment (2) is the objective of this project Synthesis of C29-C51, fragment will be prepared in the laboratory of Prof. S.M. Roberts at the University of Exeter.

Original text from CORDIS.

Participants

• University of Cambridge · CambridgeCoordinatorUnited Kingdom
• Not availableCity levelGermany

Links

• View on CORDIS